Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adipokines in Obese Asthma: A Complex Relationship Influenced More by Sex, Weight, and Oral Steroid Treatment Than Disease Severity.

Allergy·2026
Same author

Plasma proteins elevated in severe asthma despite oral steroid use and unrelated to Type-2 inflammation.

The European respiratory journal·2021
Same author

Tularaemia: a case report and review.

Przeglad epidemiologiczny·2021
Same author

Lung function fluctuation patterns unveil asthma and COPD phenotypes unrelated to type 2 inflammation.

The Journal of allergy and clinical immunology·2021
Same author

Prevalence and Population-Attributable Risk for Chronic Airflow Obstruction in a Large Multinational Study.

American journal of respiratory and critical care medicine·2020
Same author

Tuberculosis transmission in the population of patients from the Krakow Region (Poland) based on the epidemiological and molecular methods.

International journal of mycobacteriology·2019

Related Experiment Video

Updated: Jun 21, 2026

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray
07:35

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Published on: April 25, 2014

[Multidrug resistance tuberculosis - current problems].

Katarzyna Kruczak1, Ewa Nizankowska-Mogilnicka

  • 1Klinika Pulmonologii, II Katedra Chorób Wewnetrznych Collegium Medicum Uniwersytetu Jagiellonskiego w Krakowie Kierownik. krucza@gmail.com

Pneumonologia I Alergologia Polska
|July 11, 2009
PubMed
Summary

Multidrug-resistant tuberculosis (MDR-TB) is a growing global health threat. Effective control requires strategies like DOTS and DOTS-Plus to overcome challenging MDR-TB treatments.

Related Experiment Videos

Last Updated: Jun 21, 2026

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray
07:35

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Published on: April 25, 2014

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Public Health

Context:

  • Rising global incidence of multidrug-resistant tuberculosis (MDR-TB).
  • MDR-TB defined as resistance to isoniazid and rifampicin.
  • Significant challenges in treating MDR-TB due to side effects, long duration, high cost, and variable success rates.

Purpose:

  • To highlight the global challenge posed by MDR-TB.
  • To underscore the difficulties associated with current MDR-TB treatment regimens.
  • To emphasize the importance of specific control strategies for tuberculosis.

Summary:

  • MDR-TB presents a serious worldwide problem.
  • Alternative chemotherapy for MDR-TB is often difficult, expensive, and unsuccessful.
  • DOTS and DOTS-Plus strategies are crucial for effective tuberculosis control.

Impact:

  • Increased awareness of the MDR-TB crisis.
  • Understanding the limitations of current MDR-TB treatments.
  • Reinforces the need for strategic public health interventions in tuberculosis control.